Tong, M., Dominguez, C., Didsbury, J., & de la Monte, S. M. (2016). Targeting Alzheimer’s Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies. J Alzheimers Dis Parkinsonism.
Citação norma ChicagoTong, Ming, Cesar Dominguez, John Didsbury, and Suzanne M. de la Monte. "Targeting Alzheimer’s Disease Neuro-Metabolic Dysfunction With a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies." J Alzheimers Dis Parkinsonism 2016.
MLA citiranjeTong, Ming, Cesar Dominguez, John Didsbury, and Suzanne M. de la Monte. "Targeting Alzheimer’s Disease Neuro-Metabolic Dysfunction With a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies." J Alzheimers Dis Parkinsonism 2016.